Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
INTERVENTIONAL
Inicio: 29 de may de 2025
ID: NCT07035093
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
INTERVENTIONAL
Inicio: 1 de ago de 2003
ID: NCT00069784
Reclutando
Fase 2
ClinicalTrials.gov
Efficacy, Safety and Pharmacokinetics of NNC0519-0130 Once Weekly s.c. Versussemaglutide 1.0 mg and Placebo in People With Chronic Kidney Disease, With or Without Type 2 Diabetes, and With Overweight or Obesity: a Proof-of-concept and Dose-finding Study
INTERVENTIONAL
Inicio: 2 de dic de 2024
ID: NCT06717698
Completado
ClinicalTrials.gov
Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic: Cross-sectional Studio.
OBSERVATIONAL
Inicio: 1 de jul de 2020
ID: NCT06501456
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de may de 2025
ID: NCT06993792
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb Open-label Investigation of the Safety and Efficacy of DIABECELL [Immunoprotected (Alginate-Encapsulated) Porcine Islets for Xenotransplantation] in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de nov de 2012
ID: NCT01736228
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
INTERVENTIONAL
Inicio: 1 de oct de 2020
ID: NCT04492722
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 23 de sept de 2013
ID: NCT01850615
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)
INTERVENTIONAL
Inicio: 1 de ene de 2002
ID: NCT00097786
Terminado
ClinicalTrials.gov
Two Bag System vs. One Bag System for Hydration Patients With Diabetic Ketoacidosis
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01631929
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Multicentre, Randomised, Double-blind,Age-stratified, Placebo Controlled Phase III Study With an 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Patients With T2DM and Cardiovascular Disease, Who Exhibit Inadequate Glycaemic Control on Usual Care
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01042977
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function
INTERVENTIONAL
Inicio: 19 de dic de 2017
ID: NCT03315143
Completado
Fase 3
ClinicalTrials.gov
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 26 de jul de 2015
ID: NCT02420262
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00252876
Terminado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of 2mg/Day of M100907 on Sleep Maintenance Insomnia With a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: a One Year, Multi-center, Randomized, Double-blind, Placebo-controlled Study
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00464061
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastic Breast Cancer After Progression on Previous Endocrine Therapy (LITESPARK-029)
INTERVENTIONAL
Inicio: 27 de nov de 2024
ID: NCT06428396
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.
INTERVENTIONAL
Inicio: 11 de nov de 2010
ID: NCT01243424
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Placebo-Controlled Comparison of the Effects of Two Doses of LY2189265 or Exenatide on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Pioglitazone (AWARD-1: Assessment of Weekly Administration of LY2189265 in Diabetes-1)
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01064687
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of MBX 2109 in Patients With Hypoparathyroidism (Avail Study)
INTERVENTIONAL
Inicio: 8 de ago de 2024
ID: NCT06465108
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Active-Controlled, Multi-Center Extension Study to Evaluate Safety and Efficacy of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
INTERVENTIONAL
Inicio: 1 de nov de 2009
ID: NCT00998686
Anterior
1
...
32
33
34
...
434
Siguiente
Filtros